Patrick Downey

Senior Director at Ucb

Based in Brussels, Belgium

View on LinkedIn

7-day free trial · no credit card

Seniority

Director

Department

General Business & Management

Location

Brussels

Industry

Pharmaceutical Manufacturing

Company size

14K

Contact information

Reveal Patrick's email and phone

Direct contact data is gated. Sign up and reveal. You only pay for verified records.

Email

1 credit

p•••••••@ucb.com

Phone

5 credits

+32 ••• •••• ••••

You only pay for valid records. Bounced emails and disconnected numbers cost nothing.

Background

About Patrick Downey

I am the research lead and an inventor of UCB7853 (WO2019/115674A1) an alpha synuclein therapeutic antibody currently in phase 1 trials. I am also the research lead and an inventor on the granted patent of the tau therapeutic antibody Bepranemab (US10,287,343B2) which has recently completed phase 1 clinical trials (NCT03464227, NCT03605082, UCB pipeline).

Decision-makers

Other people at Ucb

Browse the Ucb team →

Build a list of verified contacts at Ucb

Free for 7 days · 50 credits · no card · only pay for verified records.

Start free

Reach more buyers like Patrick

250M+ professionals with verified email and phone. You only pay for records that actually verify.

7-day trial · no credit card · cancel anytime

Patrick Downey Email & Phone Number @ Ucb | Kipplo Discover